A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sanjeev Pathak, MD
Alkermes, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alkermes Investigational Site
Little Rock, Arkansas, United States
- Alkermes Investigational Site
Rogers, Arkansas, United States
- Alkermes Investigational Site
Cerritos, California, United States
- Alkermes Investigational Site
Culver City, California, United States
- Alkermes Investigational Site
Garden Grove, California, United States
- Alkermes Investigational Site
Lemon Grove, California, United States
- Alkermes Investigational Site
Hialeah, Florida, United States
- Alkermes Investigational Site
Chicago, Illinois, United States
- Alkermes Investigational Site
Hoffman Estates, Illinois, United States
- Alkermes Investigational Site
Flowood, Mississippi, United States
- Alkermes Investigational Site
St Louis, Missouri, United States
- Alkermes Investigational Site
Las Vegas, Nevada, United States
- Alkermes Investigational Site
Berlin, New Jersey, United States
- Alkermes Investigational Site
Austin, Texas, United States
- Alkermes Investigational Site
Garland, Texas, United States
- Alkermes Investigational Site
Richardson, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2017
- Primary completion
- 12 Mar 2019
- Completion
- 12 Mar 2019
- Last update posted
- 11 Aug 2020
- Registered enrollment
- 200
- Registry id
- NCT03345979
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.